Annals of the New York Academy of Sciences

Cover image for Vol. 1012 Redox‐Active Metals in Neurological Disorders

March 2004

Volume 1012 Redox-Active Metals in Neurological Disorders

Pages ix–x, 1–355

  1. Frontmatter

    1. Top of page
    2. Frontmatter
    3. Redox-Active Metals in Neurological Disorders: Part I. Redox-Active Metals in Neurobiology: Iron, Copper, and Zinc
    4. Part II. Redox-Active Metals in Neurobiology: Manganese and Cadmium
    5. Redox-Active Metals in Neurological Disorders: Part II. Redox-Active Metals in Neurobiology: Manganese and Cadmium
    6. Redox-Active Metals in Neurological Disorders: Part III. Redox-Active Metals and CNS Disorders: Alzheimer's Disease
    7. Redox-Active Metals in Neurological Disorders: Part IV. Redox-Active Metals and CNS Disorders: Parkinson's Disease
    8. Redox-Active Metals in Neurological Disorders: Part V. Redox-Active Metals and CNS Disorders: Other Disorders
    9. Redox-Active Metals in Neurological Disorders: Part VI. Metal Chelation Therapy in Neurological Disorders
    1. Preface (pages ix–x)

      Steven M. LeVine, James R. Connor and Hyman M. Schipper

      Version of Record online: 12 JAN 2006 | DOI: 10.1196/annals.1306.028

  2. Redox-Active Metals in Neurological Disorders: Part I. Redox-Active Metals in Neurobiology: Iron, Copper, and Zinc

    1. Top of page
    2. Frontmatter
    3. Redox-Active Metals in Neurological Disorders: Part I. Redox-Active Metals in Neurobiology: Iron, Copper, and Zinc
    4. Part II. Redox-Active Metals in Neurobiology: Manganese and Cadmium
    5. Redox-Active Metals in Neurological Disorders: Part II. Redox-Active Metals in Neurobiology: Manganese and Cadmium
    6. Redox-Active Metals in Neurological Disorders: Part III. Redox-Active Metals and CNS Disorders: Alzheimer's Disease
    7. Redox-Active Metals in Neurological Disorders: Part IV. Redox-Active Metals and CNS Disorders: Parkinson's Disease
    8. Redox-Active Metals in Neurological Disorders: Part V. Redox-Active Metals and CNS Disorders: Other Disorders
    9. Redox-Active Metals in Neurological Disorders: Part VI. Metal Chelation Therapy in Neurological Disorders
    1. Severity of Neurodegeneration Correlates with Compromise of Iron Metabolism in Mice with Iron Regulatory Protein Deficiencies (pages 65–83)

      SOPHIA R. SMITH, SHARON COOPERMAN, TIM LAVAUTE, NANCY TRESSER, MANIK GHOSH, ESTHER MEYRON-HOLTZ, WILLIAM LAND, HAYDEN OLLIVIERRE, BERNARD JORTNER, ROBERT SWITZER III, ALBEE MESSING and TRACEY A. ROUAULT

      Version of Record online: 12 JAN 2006 | DOI: 10.1196/annals.1306.006

  3. Part II. Redox-Active Metals in Neurobiology: Manganese and Cadmium

    1. Top of page
    2. Frontmatter
    3. Redox-Active Metals in Neurological Disorders: Part I. Redox-Active Metals in Neurobiology: Iron, Copper, and Zinc
    4. Part II. Redox-Active Metals in Neurobiology: Manganese and Cadmium
    5. Redox-Active Metals in Neurological Disorders: Part II. Redox-Active Metals in Neurobiology: Manganese and Cadmium
    6. Redox-Active Metals in Neurological Disorders: Part III. Redox-Active Metals and CNS Disorders: Alzheimer's Disease
    7. Redox-Active Metals in Neurological Disorders: Part IV. Redox-Active Metals and CNS Disorders: Parkinson's Disease
    8. Redox-Active Metals in Neurological Disorders: Part V. Redox-Active Metals and CNS Disorders: Other Disorders
    9. Redox-Active Metals in Neurological Disorders: Part VI. Metal Chelation Therapy in Neurological Disorders
    1. Manganese Neurotoxicity (pages 115–128)

      ALLISON W. DOBSON, KEITH M. ERIKSON and MICHAEL ASCHNER

      Version of Record online: 12 JAN 2006 | DOI: 10.1196/annals.1306.009

  4. Redox-Active Metals in Neurological Disorders: Part II. Redox-Active Metals in Neurobiology: Manganese and Cadmium

    1. Top of page
    2. Frontmatter
    3. Redox-Active Metals in Neurological Disorders: Part I. Redox-Active Metals in Neurobiology: Iron, Copper, and Zinc
    4. Part II. Redox-Active Metals in Neurobiology: Manganese and Cadmium
    5. Redox-Active Metals in Neurological Disorders: Part II. Redox-Active Metals in Neurobiology: Manganese and Cadmium
    6. Redox-Active Metals in Neurological Disorders: Part III. Redox-Active Metals and CNS Disorders: Alzheimer's Disease
    7. Redox-Active Metals in Neurological Disorders: Part IV. Redox-Active Metals and CNS Disorders: Parkinson's Disease
    8. Redox-Active Metals in Neurological Disorders: Part V. Redox-Active Metals and CNS Disorders: Other Disorders
    9. Redox-Active Metals in Neurological Disorders: Part VI. Metal Chelation Therapy in Neurological Disorders
    1. Divalent Metal Transporter 1 in Lead and Cadmium Transport (pages 142–152)

      JOSEPH P. BRESSLER, LUISA OLIVI, JAE HOON CHEONG, YONGBAE KIM and DESMOND BANNONA

      Version of Record online: 12 JAN 2006 | DOI: 10.1196/annals.1306.011

  5. Redox-Active Metals in Neurological Disorders: Part III. Redox-Active Metals and CNS Disorders: Alzheimer's Disease

    1. Top of page
    2. Frontmatter
    3. Redox-Active Metals in Neurological Disorders: Part I. Redox-Active Metals in Neurobiology: Iron, Copper, and Zinc
    4. Part II. Redox-Active Metals in Neurobiology: Manganese and Cadmium
    5. Redox-Active Metals in Neurological Disorders: Part II. Redox-Active Metals in Neurobiology: Manganese and Cadmium
    6. Redox-Active Metals in Neurological Disorders: Part III. Redox-Active Metals and CNS Disorders: Alzheimer's Disease
    7. Redox-Active Metals in Neurological Disorders: Part IV. Redox-Active Metals and CNS Disorders: Parkinson's Disease
    8. Redox-Active Metals in Neurological Disorders: Part V. Redox-Active Metals and CNS Disorders: Other Disorders
    9. Redox-Active Metals in Neurological Disorders: Part VI. Metal Chelation Therapy in Neurological Disorders
    1. Redox-Active Metals, Oxidative Stress, and Alzheimer's Disease Pathology (pages 153–163)

      XUDONG HUANG, ROBERT D. MOIR, RUDOLPH E. TANZI, ASHLEY I. BUSH and JACK T. ROGERS

      Version of Record online: 12 JAN 2006 | DOI: 10.1196/annals.1306.012

    2. Redox Metals in Alzheimer's Disease (pages 171–178)

      BOZHO M. TODORICH and JAMES R. CONNOR

      Version of Record online: 12 JAN 2006 | DOI: 10.1196/annals.1306.014

    3. Oxidative Stress and Redox-Active Iron in Alzheimer's Disease (pages 179–182)

      KAZUHIRO HONDA, GEMMA CASADESUS, ROBERT B. PETERSEN, GEORGE PERRY and MARK A. SMITH

      Version of Record online: 12 JAN 2006 | DOI: 10.1196/annals.1306.015

  6. Redox-Active Metals in Neurological Disorders: Part IV. Redox-Active Metals and CNS Disorders: Parkinson's Disease

    1. Top of page
    2. Frontmatter
    3. Redox-Active Metals in Neurological Disorders: Part I. Redox-Active Metals in Neurobiology: Iron, Copper, and Zinc
    4. Part II. Redox-Active Metals in Neurobiology: Manganese and Cadmium
    5. Redox-Active Metals in Neurological Disorders: Part II. Redox-Active Metals in Neurobiology: Manganese and Cadmium
    6. Redox-Active Metals in Neurological Disorders: Part III. Redox-Active Metals and CNS Disorders: Alzheimer's Disease
    7. Redox-Active Metals in Neurological Disorders: Part IV. Redox-Active Metals and CNS Disorders: Parkinson's Disease
    8. Redox-Active Metals in Neurological Disorders: Part V. Redox-Active Metals and CNS Disorders: Other Disorders
    9. Redox-Active Metals in Neurological Disorders: Part VI. Metal Chelation Therapy in Neurological Disorders
    1. The Relevance of Iron in the Pathogenesis of Parkinson's Disease (pages 193–208)

      MARIO E. GÖTZ, KAY DOUBLE, MANFRED GERLACH, MOUSSA B. H. YOUDIM and PETER RIEDERERE

      Version of Record online: 12 JAN 2006 | DOI: 10.1196/annals.1306.017

    2. Brain Ferritin Iron as a Risk Factor for Age at Onset in Neurodegenerative Diseases (pages 224–236)

      GEORGE BARTZOKIS, TODD A. TISHLER, IL-SEON SHIN, PO H. LU and JEFFREY L. CUMMINGS

      Version of Record online: 12 JAN 2006 | DOI: 10.1196/annals.1306.019

  7. Redox-Active Metals in Neurological Disorders: Part V. Redox-Active Metals and CNS Disorders: Other Disorders

    1. Top of page
    2. Frontmatter
    3. Redox-Active Metals in Neurological Disorders: Part I. Redox-Active Metals in Neurobiology: Iron, Copper, and Zinc
    4. Part II. Redox-Active Metals in Neurobiology: Manganese and Cadmium
    5. Redox-Active Metals in Neurological Disorders: Part II. Redox-Active Metals in Neurobiology: Manganese and Cadmium
    6. Redox-Active Metals in Neurological Disorders: Part III. Redox-Active Metals and CNS Disorders: Alzheimer's Disease
    7. Redox-Active Metals in Neurological Disorders: Part IV. Redox-Active Metals and CNS Disorders: Parkinson's Disease
    8. Redox-Active Metals in Neurological Disorders: Part V. Redox-Active Metals and CNS Disorders: Other Disorders
    9. Redox-Active Metals in Neurological Disorders: Part VI. Metal Chelation Therapy in Neurological Disorders
    1. Mitochondrial Localization of Human PANK2 and Hypotheses of Secondary Iron Accumulation in Pantothenate Kinase-Associated Neurodegeneration (pages 282–298)

      MONIQUE A. JOHNSON, YIEN MING KUO, SHAWN K. WESTAWAY, SUSAN M. PARKER, KATHERINE H. L. CHING, JANE GITSCHIER and SUSAN J. HAYFLICK

      Version of Record online: 12 JAN 2006 | DOI: 10.1196/annals.1306.023

  8. Redox-Active Metals in Neurological Disorders: Part VI. Metal Chelation Therapy in Neurological Disorders

    1. Top of page
    2. Frontmatter
    3. Redox-Active Metals in Neurological Disorders: Part I. Redox-Active Metals in Neurobiology: Iron, Copper, and Zinc
    4. Part II. Redox-Active Metals in Neurobiology: Manganese and Cadmium
    5. Redox-Active Metals in Neurological Disorders: Part II. Redox-Active Metals in Neurobiology: Manganese and Cadmium
    6. Redox-Active Metals in Neurological Disorders: Part III. Redox-Active Metals and CNS Disorders: Alzheimer's Disease
    7. Redox-Active Metals in Neurological Disorders: Part IV. Redox-Active Metals and CNS Disorders: Parkinson's Disease
    8. Redox-Active Metals in Neurological Disorders: Part V. Redox-Active Metals and CNS Disorders: Other Disorders
    9. Redox-Active Metals in Neurological Disorders: Part VI. Metal Chelation Therapy in Neurological Disorders

SEARCH

SEARCH BY CITATION